Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ICA 27243 is an activator of heteromeric voltage-gated potassium channels containing Kv7.2 and Kv7.3 subunits (Kv7.2/Kv7.3).1 It enhances rubidium efflux in an agonist-induced rubidium efflux assay using CHO cells expressing Kv7.2/Kv7.3 channels (EC50 = 0.38 µM). ICA 27243 is selective for heteromeric Kv7.2/Kv7.3 channels over homomeric Kv7.4 channels (EC50 = 7.1 µM) and is 100-300-fold selective for Kv7.2/Kv7.3 over Kv7.3/Kv7.5 channels.2 It is also selective for Kv7.2/Kv7.3 channels over a panel of neurotransmitter receptors and voltage-gated sodium channel Nav1.2 at 10 µM, as well as GABAA receptors and high voltage-activated calcium channels at 30 µM. ICA 27243 protects against maximal electroshock-induced seizures in a rat model of epilepsy (ED50 = 1.5 mg/kg).1 It also prevents hyperactivity induced by amphetamine and chlordiazepoxide, but not by amphetamine alone, without affecting basal locomotor activity in a mouse model of manic-like hyperactivity when administered at a dose of 10 mg/kg.3
WARNING This product is not for human or veterinary use.
1. N-
2. N-
3. Effects of neuronal Kv7 potassium channel activators on hyperactivity in a rodent model of mania. Behav. Brain Res. 198(2), 481-485 (2009).